ONCY
Oncolytics Biotech Inc
0.631$
-1.6%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 64.0% | 82.2% | 79.1% | 47.0% | 80.5% | 86.7% | 88.6% | 84.4% | 83.0% | 96.8% | 97.5% | 97.8% | 98.9% | 98.1% | 98.1% | 96.9% | 98.3% | 97.8% | 98.2% | 97.2% | 96.3% | 98.2% | 97.9% | 95.6% | 98.3% | 93.5% | 90.3% | |
| 63.5% | 81.3% | 78.5% | 46.3% | 10.1% | 31.4% | 7.6% | 10.4% | 21.8% | 53.1% | 91.2% | 88.4% | 91.4% | 87.5% | 89.4% | 82.3% | 87.7% | 81.5% | 65.2% | 92.2% | 72.0% | 90.9% | 89.9% | 31.2% | 89.9% | 79.0% | 68.6% | |
| 63.5% | 81.3% | 78.5% | 46.3% | 79.7% | 85.9% | 87.3% | 82.3% | 81.9% | 94.9% | 95.9% | 96.6% | 96.8% | 96.4% | 96.5% | 94.1% | 95.2% | 95.7% | 65.2% | 92.2% | 72.0% | 90.9% | 89.9% | 86.1% | 89.9% | 79.0% | 68.6% | |
| 0.3% | 0.6% | 0.5% | 0.3% | 0.2% | 0.1% | 0.1% | 0.3% | 0.3% | 0.6% | 0.2% | 0.6% | 0.2% | 0.2% | 0.4% | 1.1% | 1.2% | 0.4% | 26.5% | 0.3% | 10.5% | 0.3% | 1.9% | 1.4% | 0.0% | 0.3% | 7.6% | |
| – | 0.0% | 0.1% | 0.0% | 0.6% | 0.6% | 1.2% | 0.0% | 0.0% | 0.0% | 0.1% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | – | |
| – | 0.2% | 0.7% | 1.1% | 0.9% | 0.6% | 0.4% | 0.4% | 0.7% | 1.6% | 0.5% | 0.5% | 1.1% | 1.9% | 1.8% | 2.6% | 0.6% | 2.2% | 1.8% | 2.8% | 3.7% | 1.8% | 2.1% | 1.7% | – | – | – | |
| – | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | – | |
| 35.8% | 17.6% | 19.8% | 23.4% | 17.9% | 10.5% | 9.5% | 13.0% | 16.3% | 1.3% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | – | |
| 3.3% | 8.0% | 16.4% | 7.8% | 4.0% | 2.8% | 4.0% | 8.2% | 9.2% | 32.4% | 11.9% | 5.6% | 18.1% | 33.0% | 21.3% | 19.6% | 9.9% | 27.6% | 54.4% | 58.3% | 100.5% | 27.9% | 21.3% | 29.0% | 29.0% | 70.4% | 150.1% | |
| 1.2% | 2.8% | 12.2% | 7.0% | 3.4% | 2.4% | 3.7% | 7.8% | 9.2% | 32.4% | 11.9% | 5.6% | 18.1% | 33.0% | 21.3% | 19.6% | 9.9% | 27.6% | 28.8% | 18.9% | 65.5% | 7.9% | 5.9% | 10.6% | 10.9% | 33.1% | 80.5% | |
| – | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 8.5% | 0.0% | 1.7% | 0.7% | 0.6% | 0.6% | 0.3% | 1.4% | 2.5% | |
| 1.2% | 2.8% | 12.2% | 7.0% | 3.4% | 2.4% | 3.7% | 7.8% | 9.2% | 28.4% | 11.4% | 5.7% | 17.7% | 33.0% | 21.3% | 19.6% | 9.9% | 27.6% | 20.3% | 12.3% | 0.0% | 5.3% | 1.3% | 6.0% | 2.8% | 5.4% | 46.2% | |
| – | 0.5% | 0.5% | 0.5% | 0.4% | 0.3% | 0.3% | 0.4% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | – | |
| 96.7% | 92.0% | 83.6% | 92.2% | 96.0% | 97.2% | 96.0% | 91.8% | 76.3% | 67.6% | 84.2% | 94.4% | 81.9% | 67.0% | 78.7% | 80.4% | 90.1% | 72.4% | 45.6% | 41.7% | -0.5% | 72.1% | 78.7% | 71.0% | 71.0% | 29.6% | -50.1% | |
| -8.0% | -19.3% | -54.3% | -91.6% | -95.9% | -96.1% | -109.6% | -193.7% | -276.2% | -641.3% | -318.7% | -322.2% | -475.9% | -941.3% | -819.7% | -1,453.9% | -962.9% | -1,889.3% | -1,622.3% | -2,095.4% | -1,753.0% | -1,068.9% | -857.5% | -1,120.3% | -1,148.9% | -2,366.4% | -5,664.7% | |
| 860.5% | 8.4% | 10.2% | 12.4% | 9.4% | 7.6% | 7.4% | 11.4% | 13.8% | 31.1% | 13.9% | 14.8% | 20.7% | 36.3% | 31.2% | 53.8% | 43.3% | 85.5% | 76.8% | 107.7% | 112.6% | 117.4% | 116.6% | 155.4% | 174.2% | 378.9% | 921.4% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.